Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHB16L2 (DeltaFLU) in healthy adults
NCT01369862Phase 2Completed
- Sponsor
- AVIR Green Hills Biotechnology AG
- Start
- Jan 2011
- Primary completion
- Aug 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of DeltaFLU in influenza, sponsored by AVIR Green Hills Biotechnology AG. Started Jan 2011; status: completed.
02
Drugs
DeltaFLU
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01369862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01369862.